Improvement of skin lesions in corticosteroid withdrawal-associated severe eczema by multicomponent traditional Chinese medicine therapy.
Corticosteroid withdrawal syndrome
Eosinophil
IgE
Severe eczema
Traditional Chinese Medicine
Journal
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
ISSN: 1710-1484
Titre abrégé: Allergy Asthma Clin Immunol
Pays: England
ID NLM: 101244313
Informations de publication
Date de publication:
09 Jul 2021
09 Jul 2021
Historique:
received:
16
10
2020
accepted:
03
05
2021
entrez:
10
7
2021
pubmed:
11
7
2021
medline:
11
7
2021
Statut:
epublish
Résumé
We recently showed that multicomponent traditional Chinese medicine (TCM) therapy had steroid-sparing effects in moderate-to-severe eczema. We sought to evaluate TCM effects in severe eczema in a 7-year-old male with refractory disease and corticosteroid withdrawal syndrome. Prior to referral, the patient had been treated since infancy with increasingly intensive standard of care, including high-dose topical and systemic corticosteroid and antibiotic therapy and was unable to tolerate further steroid treatment. The patient was administered a combination of oral and topical TCM for 17 months following discontinuation of his steroid regimen. His overall medical condition was assessed by SCORAD criteria and laboratory evaluations of serum IgE, absolute eosinophil count, and liver and kidney function tests. The patient showed rapid improvement of clinical measures of disease after starting TCM therapy, with marked improvement of sleep quality within the first week, complete resolution of itching, oozing, and erythema at 2 weeks, and a 79% and 99% decrease in his SCORAD values after one month and 3-6 months of TCM, respectively. Serum total IgE decreased by 75% (from 19,000 to 4630 (kIU/L), and absolute eosinophil counts decreased by 60% (from 1000 to 427 cells/μL) after 12 months of treatment. The patient did not require oral or topical steroids during the 17-month trial of TCM. TCM was tapered without complications. His dermatologic manifestations continued to be well-controlled 3 months after discontinuation. This case study suggests TCM should be further evaluated in controlled clinical studies of patients with severe, refractory eczema and steroid withdrawal syndrome.
Identifiants
pubmed: 34243796
doi: 10.1186/s13223-021-00555-0
pii: 10.1186/s13223-021-00555-0
pmc: PMC8268267
doi:
Types de publication
Letter
Langues
eng
Pagination
68Informations de copyright
© 2021. The Author(s).
Références
J Am Acad Dermatol. 2015 Mar;72(3):541-549.e2
pubmed: 25592622
Br J Pharmacol. 2008 May;154(1):165-73
pubmed: 18332856
Phytother Res. 2013 Sep;27(9):1381-91
pubmed: 23165939
JAKSTAT. 2013 Apr 1;2(2):e23435
pubmed: 24058807
Ann Allergy Asthma Immunol. 2018 Jul;121(1):135-136
pubmed: 29530759
Int J Mol Med. 2015 Oct;36(4):985-91
pubmed: 26239419
Evid Based Complement Alternat Med. 2017;2017:6026434
pubmed: 28713436
Evid Based Complement Alternat Med. 2015;2015:620472
pubmed: 25793002
J Clin Med. 2015 Apr 03;4(4):593-613
pubmed: 26239349
N Engl J Med. 2007 Oct 18;357(16):1608-19
pubmed: 17881745